Welcome to Medpharm Publications

Medpharm Publications was founded in 1988 and has established itself as the largest medical and pharmaceutical journal publisher in South Africa.

With a publications list of more than ten titles comprising of over fifty journal editions, Medpharm Publications reach more than 40 000 healthcare workers countrywide with printed editions, and has established a global audience with the online editions.

The majority of Medpharm Publications’ journals are associated with professional or scholarly societies and acts as the official South African mouthpiece in the associated discipline. All journals are web-based, most of which are fully peer-reviewed, with five titles accredited by the South African Department of Higher Education and Training (DHET) to earn research subsidies for academic departments.

As a publisher, passionate about journal publishing, we believe that South African researchers and clinicians can and will make a significant contribution to world medical literature.

BREAST CANCER ON THE RISE IN YOUNGER SOUTH AFRICAN WOMEN

Breast cancer, the most prevalent cancer among South African women, is increasingly being detected in women under 40. This trend mirrors global patterns, where younger women are being diagnosed with more aggressive forms of the disease, underscoring the need for early detection and awareness.

SA Heart Congress unites Cardiologists for better care

The SA Heart Annual Congress will take place from 8–10 November at the Sandton Convention Centre, Johannesburg. The three-day Congress, themed ‘Cardiology Connections,’ will promote collaboration and dialogue among local and international Cardiology professionals.

Adcock Ingram Critical Care partners with Global MedTech Giant Medline

Adcock Ingram Critical Care, a leading manufacturer and supplier of hospital and critical care products in Southern Africa, is taking another step towards improving patient care in the region through a strategic alliance with Medline.

Sanofi commits to affordable insulin pens for diabetic patients

Over the past few years, there has been a notable shift towards the use of insulin pens in the public sector, replacing traditional vials. This transition has been driven by the advantages insulin pens offer, including improved dosing accuracy, ease of use for patients, greater convenience, and better adherence to treatment.

Revolutionising Gastrointestinal Care: Austell Pharmaceuticals Launches Tasectan Duo, South Africa’s First Dual-Action Diarrhoea Treatment

Austell Pharmaceuticals has recently announced the launch of its latest product, Tasectan Duo, an innovative solution for the treatment of diarrhoea.